Alexa Meara

2.3k total citations · 1 hit paper
49 papers, 1.2k citations indexed

About

Alexa Meara is a scholar working on Oncology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexa Meara has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 14 papers in Rheumatology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexa Meara's work include Cancer Immunotherapy and Biomarkers (15 papers), Systemic Lupus Erythematosus Research (8 papers) and Patient-Provider Communication in Healthcare (6 papers). Alexa Meara is often cited by papers focused on Cancer Immunotherapy and Biomarkers (15 papers), Systemic Lupus Erythematosus Research (8 papers) and Patient-Provider Communication in Healthcare (6 papers). Alexa Meara collaborates with scholars based in United States, Canada and France. Alexa Meara's co-authors include Salem Almaani, Brad H. Rovin, Lynn A. Fussner, David Jayne, Sergey V. Brodsky, John F. P. Bridges, Lee S. Simon, Carolyn J. Presley, Timothy M. Pawlik and Elizabeth Palmer Kelly and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alexa Meara

43 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update on Lupus Nephritis

2016 595 citations Salem Almaani, Alexa Meara et al. Clinical Journal of the American Society of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alexa Meara United States	15	591	351	270	235	152	49	1.2k
Stacy P. Ardoin United States	23	599 1.0×	448 1.3×	147 0.5×	70 0.3×	73 0.5×	86	1.5k
Arijit Ganguli United States	22	439 0.7×	360 1.0×	65 0.2×	196 0.8×	126 0.8×	90	1.4k
Keith A. Betts United States	23	366 0.6×	582 1.7×	37 0.1×	437 1.9×	328 2.2×	129	2.0k
Susan G. Barr Canada	26	1.6k 2.8×	930 2.6×	134 0.5×	58 0.2×	124 0.8×	45	2.3k
Kathleen Joyce United States	11	1.2k 2.1×	579 1.6×	795 2.9×	120 0.5×	45 0.3×	17	1.6k
Niti Goel United States	20	1.2k 2.1×	595 1.7×	26 0.1×	143 0.6×	108 0.7×	91	1.9k
Chris Wincup United Kingdom	17	470 0.8×	265 0.8×	29 0.1×	76 0.3×	78 0.5×	52	851
Maria Dall’Era United States	29	2.2k 3.8×	1.5k 4.4×	503 1.9×	89 0.4×	302 2.0×	99	3.0k
Fangfang Sun China	15	222 0.4×	169 0.5×	44 0.2×	115 0.5×	37 0.2×	65	687
Daan ten Bokkel Huinink Netherlands	15	77 0.1×	160 0.5×	64 0.2×	501 2.1×	468 3.1×	32	1.2k

Countries citing papers authored by Alexa Meara

Since Specialization

Citations

This map shows the geographic impact of Alexa Meara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexa Meara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexa Meara more than expected).

Fields of papers citing papers by Alexa Meara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexa Meara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexa Meara. The network helps show where Alexa Meara may publish in the future.

Co-authorship network of co-authors of Alexa Meara

This figure shows the co-authorship network connecting the top 25 collaborators of Alexa Meara. A scholar is included among the top collaborators of Alexa Meara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexa Meara. Alexa Meara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mansour, Anthony G., et al.. (2025). An atypical presentation of immune checkpoint inhibitor associated myositis with normal creatine kinase: a case report. Frontiers in Immunology. 16. 1661534–1661534.

Zhao, Shushan, et al.. (2025). Evaluating the Efficacy of Tocilizumab for Steroid-Refractory Immune Checkpoint Inhibitor Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A3109–A3109. 1 indexed citations

Singh, Jasvinder A., Larry R. Hearld, Seth A. Eisen, et al.. (2025). Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics. Lara D. Veeken. 64(8). 4631–4640.

Meara, Alexa, et al.. (2025). Immunotherapy Complications. Emergency Medicine Clinics of North America. 43(3). 489–501. 1 indexed citations

Zhao, Songzhu, Lai Wei, Joshua A. Englert, et al.. (2025). Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis. Cancer Immunology Immunotherapy. 74(2). 46–46.

Klionsky, Yael, Alexa Meara, & Pankti Reid. (2024). Immunotherapy Toxicity Management in Clinical Practice. Rheumatic Disease Clinics of North America. 50(2). 229–239. 1 indexed citations

Redman, Charles, et al.. (2024). Graduate medical education success coaching for residents and fellows: a single-institution real-world experience. Medical Education Online. 29(1). 2342102–2342102. 2 indexed citations

Ghosh, Nilasha, Bridget Jivanelli, Namrata Singh, et al.. (2024). The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis. Rheumatic Disease Clinics of North America. 50(2). 325–335. 2 indexed citations

Elsaid, Mohamed I., Alexa Meara, Dwight H. Owen, et al.. (2024). Risk and impacts of drug-induced liver injury (DILI) due to immune-checkpoint inhibitors (ICI) on overall survival in patients with newly diagnosed cancer: A retrospective cohort study.. Journal of Clinical Oncology. 42(16_suppl). 12049–12049. 1 indexed citations

10.

Peng, Jing, et al.. (2024). Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis. The Oncologist. 29(11). e1575–e1585. 1 indexed citations

11.

Husain, Marium, Rebecca Hoyd, Alexa Meara, et al.. (2023). De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.. Journal of Clinical Oncology. 41(16_suppl). 9569–9569. 2 indexed citations

12.

Simon, Lee S., Peter Tugwell, Maria Antonietta D’Agostino, et al.. (2022). Physicians’ vs patients’ global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies. Seminars in Arthritis and Rheumatism. 56. 152074–152074. 1 indexed citations

13.

Tinoco, Gabriel, Songzhu Zhao, Lai Wei, et al.. (2022). Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival. Journal of Cancer Research and Clinical Oncology. 149(5). 2235–2242. 25 indexed citations

14.

Almaani, Salem, Lynn A. Fussner, Sergey V. Brodsky, Alexa Meara, & David Jayne. (2021). ANCA-Associated Vasculitis: An Update. Journal of Clinical Medicine. 10(7). 1446–1446. 96 indexed citations

15.

Zhao, Songzhu, Mingjia Li, Sandip H. Patel, et al.. (2021). Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival. Cancer Immunology Immunotherapy. 71(5). 1157–1165. 24 indexed citations

16.

Roy, Upal, Sarah Janse, Ellen M. Janssen, et al.. (2019). MA24.03 Factors Impacting Patients’ Worries (Accessing Treatment, Treatment Toxicity, & Emotional Burden) Associated with Lung Cancer Treatments. Journal of Thoracic Oncology. 14(10). S347–S347. 1 indexed citations

17.

Aydin, Sibel Z., Joanna Robson, Antoine G. Sreih, et al.. (2019). Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018. The Journal of Rheumatology. 46(9). 1198–1201. 24 indexed citations

18.

Kelly, Elizabeth Palmer, et al.. (2019). Understanding the Type of Support Offered Within the Caregiver, Family, and Spiritual/Religious Contexts of Cancer Patients. Journal of Pain and Symptom Management. 58(1). 56–64. 35 indexed citations

19.

Kelly, Elizabeth Palmer, et al.. (2018). Reciprocity within patient-physician and patient-spouse/caregiver dyads: insights into patient-centered care. Supportive Care in Cancer. 27(4). 1237–1244. 8 indexed citations

20.

Almaani, Salem, Alexa Meara, & Brad H. Rovin. (2016). Update on Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 12(5). 825–835. 595 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact